Author

Thibault Payen

Observed name: T. Payen

Institution: Groupe Hospitalier de la Région de Mulhouse et Sud Alsace

Observed institution: Groupe Hospitalier de la Région de Mulhouse et Sud Alsace

OpenAlex ID: A5019529340

Real world data of efficacy and safety of erlotinib as first-line TKI treatment in EGFR mutation-positive advanced non-small cell lung cancer: Results from the EGFR-2013-CPHG study

2020 · T. Payen, J. Trédaniel, et al. · Respiratory Medicine and Research · 10

Mid-term pulmonary sequelae after hospitalisation for COVID-19: The French SISCOVID cohort

2022 · George Calcaianu, Samuel Degoul, et al. · Respiratory Medicine and Research · 7

Long-term corticosteroid therapy for patients with severe coronavirus disease 2019 (COVID-19)

2021 · George Calcaianu, Samuel Degoul, et al. · medRxiv · 1

EP1.01-05 EGFR-2013-CPHG, a Real-World Study of EGFR Mutant Advanced Non-Small-Cell Lung Cancer Patients Treated with Erlotinib

2019 · D. Debieuvre, J. Tredaniel, et al. · Journal of Thoracic Oncology

Works count: 4

Citation count: 18

H-index: 2

I10-index: 1